Vitamin B-6 and riboflavin, their metabolic interaction, and relationship with MTHFR genotype in adults aged 18-102 years

Background: The generation of the active form of vitamin B-6. pyridoxal 5'-phosphate (PLP), in tissues is dependent upon riboflavin as flavin mononucleotide, but whether this interaction is important for maintaining vitamin B-6 status is unclear. Objective: To investigate vitamin B-6 and riboflavin status, their metabolic interaction, and relationship with methylenetetrahydrofolate reductase (MTHFR) genotype in adulthood. Methods: Data from 5612 adults aged 18-102 y were drawn from the Irish National Adult Nutrition Survey (NANS; populationbased sample) and the Trinity-Ulster Department of Agriculture (TUDA) and Genovit cohorts (volunteer samples). Plasma PLP and erythrocyte glutathione reductase activation coefficient (EGRac), as a functional indicator of riboflavin, were determined. Results: Older (>= 65 y) compared with younger (<65 y) adults had significantly lower PLP concentrations (P < 0.001). A stepwise decrease in plasma PLP was observed across riboflavin categories, from optimal (EGRac <= 1.26), to suboptimal (EGRac: 1.27-1.39), to deficient (EGRac >= 1.40) status, an effect most pronounced in older adults (mean +/- SEM: 76.4 +/- 0.9 vs 65.0 +/- 1.1 vs 55.4 +/- 1.2 nmol/L; P < 0.001). In individuals with the variant MTHFR 677TT genotype combined with riboflavin deficiency, compared with non-TT (CC/CT) genotype participants with sufficient riboflavin, we observed PLP concentrations of 52.1 +/- 2.9 compared with 76.8 +/- 0.7 nmol/L (P < 0.001). In participants with available dietary data (i.e., NANS cohort, n = 936), PLP was associated with vitamin B-6 intake (nonstandardized regression coefficient beta: 2.49; 95% CI 1.75. 3.24; P < 0.001), supplement use (beta: 81.72; 95% CI: 66.01, 97.43; P < 0.001), fortified food (beta: 12.49; 95% CI: 2.08, 22.91; P = 0.019), and EGRac (beta: -65.81; 95% CI: -99.08, -32.54; P < 0.001). along with BMI (beta: -1.81; 95% CI: -3.31, -0.30; P = 0.019). Conclusions: These results are consistent with the known metabolic dependency of PLP on flavin mononucleotide (FMN) and suggest that riboflavin may be the limiting nutrient for maintaining vitamin B-6 status, particularly in individuals with the MTHFR 677TT genotype. Randomized trials arc necessary to investigate the PLP response to riboflavin intervention within the dietary range. The TUDA study and the NANS are registered at www.clinicaltrials.gov as NCT02664584 (27 January 2016) and NCT03374748 (15 December 2017), respectively. Clinical Trial Registry details: TrinityUlster-Department of Agriculture (TUDA) study. ClinicalTrials.gov no. NCT02664584 (January 27th 2016); National Adult Nutrition Survey (NANS), ClinicalTrials.gov no. NCT03374748 (December 15th 2017).

Automated summary

The concentration of vitamin B-6 is lower in older adults, and riboflavin levels affect the status of vitamin B-6, especially in older individuals. The combination of the MTHFR 677TT genotype with riboflavin deficiency leads to a decrease in vitamin B-6 levels. Intake of vitamin B-6, supplement use, and EGRac are associated with PLP levels.